AI Image
Tapeworm drug could treat disease that affects 190 million women
New York Post • • health
Key Points:
- Researchers have developed a promising treatment for endometriosis using niclosamide, an FDA-approved anti-worm drug, enhanced with nanotechnology to target painful lesions outside the uterus in mice.
- The modified drug uses a dendrimer molecule and a folate receptor to specifically target rogue immune cells driving lesion growth and inflammation, releasing the medication slowly inside affected cells.
- In mouse models, a single injection significantly reduced pain and halted lesion growth, offering hope beyond current treatments that only alleviate symptoms and often cause side effects.
- Despite promising results, challenges remain in translating the treatment to humans since mice do not menstruate or naturally develop endometriosis; further testing and clinical trials are needed.
- The study highlights the potential of repurposing existing drugs for endometriosis, a disease affecting 1 in 10 women of reproductive age worldwide, with many expressing interest in future clinical trials.
